
Atrys Reports 9.4% Revenue Growth and 21.3% EBITDA Increase in First Half of 2026
Atrys Reports Strong First-Half 2026 Growth as Revenue Rises 9.4% and EBITDA Climbs 21.3% Atrys Health, a healthcare company specializing in oncology, telediagnostics, pathological anatomy and nuclear medicine, reported solid financial and operational performance for the first half of 2026.…













